Industry
Biotechnology
Companies applying molecular biology to develop therapeutics and diagnostics. High-risk/high-reward: valuations tie to clinical trial success, intellectual property and partnerships with big pharma.
Total Companies
1 361
1 285 stocks
| Company | Last Price | Price Change | Market Cap | ||
|---|---|---|---|---|---|
|
|
|
Abbvie Inc
ABBV
|
$227.68 |
-0.5%
|
$402.4B |
|
|
|
Astria Therapeutics Inc
ATXS
|
$5 784.3 |
+45 880.1%
|
$330.2B |
|
|
|
Amgen Inc
AMGN
|
$377.64 |
+0.5%
|
$203.4B |
|
|
|
Gilead Sciences Inc
GILD
|
$146 |
-1.6%
|
$181.1B |
|
|
|
Vertex Pharmaceuticals Inc
VRTX
|
$492.38 |
+1.5%
|
$124.9B |
|
|
|
Regeneron Pharmaceuticals Inc
REGN
|
$774.66 |
-2.1%
|
$81.9B |
|
|
|
argenx SE
ARGX
|
€630.6 |
0%
|
$46B |
|
|
|
CSL Ltd
CSL
|
AU$142.52 |
0%
|
$48.8B |
|
|
|
Alnylam Pharmaceuticals Inc
ALNY
|
$320.43 |
+0.6%
|
$42.3B |
1 280 results hidden
Create a free account to unlock additional access and upgrade to see all results
Create Free Account
